Perspectives in Rheumatic Diseases

September 7, 2023 – September 9, 2023

THE VENETIAN LAS VEGAS
LAS VEGAS, NEVADA

In-Person

swoosh
swoosh

ACCREDITATION

TARGET AUDIENCE

This activity is designed for Rheumatologist, Residents/Fellows, Internists, Family Physicians, Physician Assistants, Nurse Practitioners, Nurses, Pharmacist, and other health professionals interested in Rheumatic Diseases.

 

LEARNING OBJECTIVES

After participating in this activity, learners should be better able to: [LIST] [ITEM]Assess current and emerging immunosuppressive, anti-inflammatory, and disease-modifying treatments for rheumatic diseases considering pathophysiologic targets; mechanisms of action; safety and efficacy data; dosing, adherence and access; and impact on therapeutic selection. [ITEM]Describe evidence-based guidance for mitigating complications associated with rheumatic diseases. [ITEM]Evaluate treatment options for the management of rheumatic manifestations of autoimmune diseases and atypical manifestations of rheumatic diseases. [ITEM]Apply current guideline recommendations and shared decision-making strategies that improve the management of patients with rheumatic diseases.

 

ACCREDITATION STATEMENTS

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGOGAME][PIM]

[bold]Physician Continuing Medical Education[/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 20.25 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education[/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 20.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates. [bold]Continuing Pharmacy Education[/bold] Postgraduate Institute for Medicine designates this continuing education activity for 20.25 contact hours (2.25 CEUs) of the Accreditation Council for Pharmacy Education. [bold]Continuing Physician Assistants Education[/bold] AAPA accepts certificates of participation for educational activities certified for [italic]AMA PRA Category 1 Credit™[/italic] from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20.25 [italic]Category 1[/italic] credits for completing this activity. [bold]American Board of Internal Medicine MOC[/bold] [ABIMMOC] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. [bold][underline]Disclosure of Conflicts of Interest[/underline][/bold] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.